InflaRx NV (IFRX)

1.44 +0.01 (+0.70%) USD  |  NASDAQ  |  May 31, 16:00
1.435 0.00 (0.00%) After-Hours: 20:00
More

InflaRx Cash from Financing (Quarterly): -0.0931M for March 31, 2024

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2017. Upgrade now.
Date Value
March 31, 2024 -0.0931M
December 31, 2023 -0.4306M
September 30, 2023 -0.1904M
June 30, 2023 57.95M
March 31, 2023 0.0324M
December 31, 2022 2.318M
September 30, 2022 -0.0812M
June 30, 2022 -0.092M
March 31, 2022 -0.1019M
December 31, 2021 0.2088M
September 30, 2021 -1.716M
June 30, 2021 -0.1013M
March 31, 2021 74.47M
December 31, 2020 -0.3573M
September 30, 2020 10.49M
Date Value
June 30, 2020 0.4422M
March 31, 2020 -0.0975M
December 31, 2019 -0.0988M
September 30, 2019 -0.0902M
June 30, 2019 -0.0783M
March 31, 2019 -0.0622M
December 31, 2018 0.8961M
September 30, 2018 -1.012M
June 30, 2018 58.73M
March 31, 2018 0.00
December 31, 2017 121.45M
September 30, 2017 0.113M
June 30, 2017 0.0525M
March 31, 2017 1.598M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-1.716M
Minimum
Sep 2021
74.47M
Maximum
Mar 2021
7.119M
Average
-0.0911M
Median

Cash from Financing (Quarterly) Benchmarks

Affimed NV -1.482M
MorphoSys AG --
BioNTech SE -8.472M
Immatics NV 189.70M
CureVac NV -1.221M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly) -16.15M
Cash from Investing (Quarterly) 29.27M
Free Cash Flow -45.89M
Free Cash Flow Per Share (Quarterly) -0.2746
Free Cash Flow to Equity (Quarterly) -16.17M
Free Cash Flow to Firm (Quarterly) -16.17M
Free Cash Flow Yield -54.54%